Stay updated on Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Version numbers updated from v3.4.0 to v3.4.1; no user-facing changes detected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T03:44:32.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Added a glossary toggle, updated QC-related labels to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and updated the revision tag to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-28T22:23:57.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision: v3.3.4 is now displayed instead of v3.3.3. This is a minor site version update and does not alter any study details or user-facing content.
    Difference
    0.1%
    Check dated 2026-01-14T07:27:36.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    A consolidated Locations section has been added listing study sites in Arizona, District of Columbia, Minnesota, Missouri, New York, South Dakota, and Texas, and the page revision updated to v3.3.3. The previous state-specific subsections (Arizona Locations, District of Columbia Locations, Minnesota Locations, Missouri Locations, New York Locations, South Dakota Locations, Texas Locations) and the HHS Vulnerability Disclosure link were removed.
    Difference
    0.9%
    Check dated 2025-12-23T23:59:31.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.1 to v3.3.2; no changes to the study content or structure were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T12:53:28.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    The change is a minor revision log update from v3.2.0 to v3.3.1; no modifications to core study details, eligibility criteria, or outcome measures are evident. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T12:10:26.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial page.